Stay informed with the latest litigation news. Explore now

IP Verse

Aventis Pharma competitive analysis

Latest publications and patents of Aventis Pharma New

Explore the latest publications and patents granted to Aventis Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 11, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Aventis Pharma

EP2493466
Mar 10, 2021Novel Antitumoral Use Of CabazitaxelGranted And Under Opposition
EP3294285
Dec 18, 2019Cabazitaxel And Its Use For Treating CancerRevoked
EP2678011
Jun 26, 2019Antitumoral Combination Comprising Cabazitaxel And CisplatinRevoked

Latest patents of Aventis Pharma opposed by its competitors

Explore Aventis Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 18, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2493466
Mar 10, 2021Novel Antitumoral Use Of Cabazitaxel13
EP3294285
Dec 18, 2019Cabazitaxel And Its Use For Treating Cancer9
EP2678011
Jun 26, 2019Antitumoral Combination Comprising Cabazitaxel And Cisplatin1

Latest PTAB cases involving Aventis Pharma New

Discover the latest PTAB cases involving Aventis Pharma, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 17, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Aventis Pharma

IPR2019-00136Oct 31, 2018NEPTUNE GENERICSAVENTIS PHARMAInstitution Denied
IPR2016-00712Mar 15, 2016MYLAN LABORATORIESAVENTIS PHARMAFinal Written Decision
IPR2016-00627Feb 17, 2016MYLAN LABORATORIESAVENTIS PHARMAInstitution Denied

Top competitors of Aventis Pharma

Top competitors of Aventis Pharma based on patent oppositions.